Ameritas Investment Partners’s Century Therapeutics IPSC Stock Holding History

Ameritas Investment Partners’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27.4K	Buy	+11,185	New	+$25.6K	﹤0.01%	2597
2025 Q2	–	Sell	-905	Closed	-$431	–	3267
2025 Q1	$431	Hold	905	–	–	﹤0.01%	3122
2024 Q4	$914	Hold	905	–	–	﹤0.01%	3122
2024 Q3	$1.55K	Hold	905	–	–	﹤0.01%	3105
2024 Q2	$2.31K	Hold	905	–	–	﹤0.01%	3091
2024 Q1	$3.78K	Hold	905	–	–	﹤0.01%	2983
2023 Q4	$3K	Hold	905	–	–	﹤0.01%	3032
2023 Q3	$1.81K	Hold	905	–	–	﹤0.01%	3078
2023 Q2	$2.86K	Hold	905	–	–	﹤0.01%	3071
2023 Q1	$3.14K	Hold	905	–	–	﹤0.01%	2929
2022 Q4	$4.1K	Hold	905	–	–	﹤0.01%	2947
2022 Q3	$8K	Hold	905	–	–	﹤0.01%	2852
2022 Q2	$7K	Hold	905	–	–	﹤0.01%	2912
2022 Q1	$11K	Hold	905	–	–	﹤0.01%	2761
2021 Q4	$14K	Hold	905	–	–	﹤0.01%	2786
2021 Q3	$23K	Buy	+905	New	+$24.5K	﹤0.01%	2622

Other funds holding IPSC

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Ameritas Investment Partners's IPSC Position: Q2 2026 in Review

Ameritas Investment Partners opened a new position in Century Therapeutics (IPSC) in Q2 2026: 11,185 shares worth $27.4K. The stake represents ﹤0.01% of the portfolio and ranks #2597 among its holdings. This is a return to the name: Ameritas Investment Partners previously reported a position in IPSC as recently as Q1 2025.

Ameritas Investment Partners first reported a position in IPSC in Q3 2021 and has held it in 16 quarters since. 100 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

Ameritas Investment Partners held 11,185 shares of Century Therapeutics worth $27.4K as of Q2 2026.
Century Therapeutics was a new Ameritas Investment Partners position in Q2 2026.
Century Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2597 holding.
Ameritas Investment Partners first reported a position in Century Therapeutics in Q3 2021 and has held it in 16 quarters since.
100 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.